Author Correction: T cell malignancies after CAR T cell therapy in the DESCAR-T registry

Remy Dulery^#^{1

2}, Vincent Guiraud^#³, Sylvain Choquet^#⁴, Catherine Thieblemont⁵, Emmanuel Bachy⁶, Stéphane Barete⁷, Ève Todesco³, Bertrand Arnulf⁸, Nicolas Boissel⁹, André Baruchel¹⁰, Jacques-Olivier Bay¹¹, Steven Le Gouill¹², Roch Houot¹³

Affiliations

¹ Department of Clinical Hematology and Cellular Therapy, Sorbonne University, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, INSERM, UMRs 938, Centre de recherche Saint-Antoine (CRSA), Paris, France. remy.dulery@aphp.fr.
² Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. remy.dulery@aphp.fr.
³ Department of Virology, Sorbonne University, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France.
⁴ Department of Clinical Hematology, Sorbonne University, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
⁵ Hemato-oncology, Paris Cité University, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris, France.
⁶ Hematology Department, Hospices Civils de Lyon, Pierre-Bénite, France.
⁷ Unit of Dermatology, Sorbonne University, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
⁸ Department of Immuno-Hematology, Paris Cité University, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
⁹ Hematology Adolescents and Young Adult Unit, Paris Cité University, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, URP-3518, Institut de Recherche Saint-Louis, Paris, France.
¹⁰ Department of Pediatric Hematology and Immunology, Paris Cité University, Hôpital Universitaire Robert Debré, Assistance Publique-Hôpitaux de Paris, EA3518, Institut de Recherche Saint-Louis, Paris, France.
¹¹ Department of Adult Clinical Hematology and Cellular Therapy, CHU Clermont-Ferrand, Clermont-Ferrand, France.
¹² Department of Hematology, Versailles Saint-Quentin University, Institut Curie, Laboratoire d'Imagerie Translationnelle en Oncologie (LITO), U1288 Inserm/Institut Curie Centre de recherche, Saint-Cloud, France.
¹³ Department of Hematology, University Hospital of Rennes, UMR U1236, INSERM, University of Rennes, French Blood Establishment, Rennes, France.

^# Contributed equally.

PMID: 40281205
DOI: 10.1038/s41591-025-03717-4

Published Erratum

Author Correction: T cell malignancies after CAR T cell therapy in the DESCAR-T registry

Remy Dulery et al. Nat Med. 2025 Jul.

. 2025 Jul;31(7):2452.

doi: 10.1038/s41591-025-03717-4.

Authors

Affiliations

¹ Department of Clinical Hematology and Cellular Therapy, Sorbonne University, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, INSERM, UMRs 938, Centre de recherche Saint-Antoine (CRSA), Paris, France. remy.dulery@aphp.fr.
² Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. remy.dulery@aphp.fr.
³ Department of Virology, Sorbonne University, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France.
⁴ Department of Clinical Hematology, Sorbonne University, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
⁵ Hemato-oncology, Paris Cité University, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris, France.
⁶ Hematology Department, Hospices Civils de Lyon, Pierre-Bénite, France.
⁷ Unit of Dermatology, Sorbonne University, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
⁸ Department of Immuno-Hematology, Paris Cité University, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
⁹ Hematology Adolescents and Young Adult Unit, Paris Cité University, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, URP-3518, Institut de Recherche Saint-Louis, Paris, France.
¹⁰ Department of Pediatric Hematology and Immunology, Paris Cité University, Hôpital Universitaire Robert Debré, Assistance Publique-Hôpitaux de Paris, EA3518, Institut de Recherche Saint-Louis, Paris, France.
¹¹ Department of Adult Clinical Hematology and Cellular Therapy, CHU Clermont-Ferrand, Clermont-Ferrand, France.
¹² Department of Hematology, Versailles Saint-Quentin University, Institut Curie, Laboratoire d'Imagerie Translationnelle en Oncologie (LITO), U1288 Inserm/Institut Curie Centre de recherche, Saint-Cloud, France.
¹³ Department of Hematology, University Hospital of Rennes, UMR U1236, INSERM, University of Rennes, French Blood Establishment, Rennes, France.

^# Contributed equally.

PMID: 40281205
DOI: 10.1038/s41591-025-03717-4

No abstract available

PubMed Disclaimer

Erratum for

T cell malignancies after CAR T cell therapy in the DESCAR-T registry.
Dulery R, Guiraud V, Choquet S, Thieblemont C, Bachy E, Barete S, Todesco È, Arnulf B, Boissel N, Baruchel A, Bay JO, Le Gouill S, Houot R. Dulery R, et al. Nat Med. 2025 Apr;31(4):1130-1133. doi: 10.1038/s41591-024-03458-w. Epub 2025 Jan 8. Nat Med. 2025. PMID: 39779930

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: T cell malignancies after CAR T cell therapy in the DESCAR-T registry

Affiliations

Author Correction: T cell malignancies after CAR T cell therapy in the DESCAR-T registry

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources